Work

S1827 Elafibranor for the Treatment of Primary Biliary Cholangitis: Study Designs of the ELFIDENCE, ELSPIRE, and ELFINITY Phase III/IV Trials

Year: 2024

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001036676.42521.e3

Authors: Marcelo Kugelmas, Kris V. Kowdley, Christina Hanson, Mordechai Rabinovitz, Marwan Sleiman, Richard Allan, Katerine Boutros, Ana Bozas, Christelle Pommie, Jianfen Shu, Nuno Antunes, Jörn M. Schattenberg

Institutions: Liver Institute Northwest, University of Pittsburgh, Ipsen (France), Ipsen (United Kingdom), Saarland University

Language: English

Topic: Liver Diseases and Immunity

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403721737

Cites:

Cited by:

Related to: 10